3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
20
Meningioma
6
Gastro-enteropancreatic neuroendocrine tumor
6
Pheochromocytoma
3
Paraganglioma
3
Prostatic Neoplasms
2
Neuroblastoma
2
Medulloblastoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Carcinoma, Merkel Cell
2
Adenoma, Islet Cell
2
Somatostatin Receptor-positive Neuroendocrine Tumor
1
Sarcoma, Synovial
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Hypertension
1
Extensive Stage Small Cell Lung Cancer
1
Esthesioneuroblastoma, Olfactory
1
Disease Progression
1
Digestive System Neuroendocrine Tumor G1
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma
1
Carcinoid Tumor
1
Interventions
Bevacizumab
3
Leucovorin
2
Irinotecan
2
Fluorouracil
2
repotrectinib
1
pembrolizumab
1
encorafenib
1
Oxaliplatin
1
Oviposition
1
Levoleucovorin
1
Drug Therapy
1
Drainage
1
Cetuximab
1
Capecitabine
1
Artesunate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Intestinal Neoplasms
×
lutetium Lu 177 dotatate
×
1 year
×
Clear all
No trials found.